Skip to main content
S 259 117th Congress Senate Health Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions

Safe and Affordable Drugs from Canada Act of 2021

Introduced: February 4, 2021 Introduced by: Klobuchar, Amy Democratic · Minnesota See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 4, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 4, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Safe and Affordable Drugs from Canada Act of 2021

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA shall publish a list of approved Canadian pharmacies on a website.

What's happening now February 4, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 832 Identical bill Safe and Affordable Drugs from Canada Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 10
All 10 Democratic 7 Republican 2 Independent 1
D
Peters, Gary C.
Michigan · Feb 8, 2021
 D
Baldwin, Tammy
Wisconsin · Feb 4, 2021
 R
Collins, Susan M.
Maine · Feb 4, 2021
 R
Grassley, Chuck
Iowa · Feb 4, 2021
 D
Hassan, Margaret Wood
New Hampshire · Feb 4, 2021
 I
King, Angus S., Jr.
Maine · Feb 4, 2021
 D
Merkley, Jeff
Oregon · Feb 4, 2021
 D
Shaheen, Jeanne
New Hampshire · Feb 4, 2021
 D
Whitehouse, Sheldon
Rhode Island · Feb 4, 2021
 D
Wyden, Ron
Oregon · Feb 4, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 259: Safe and Affordable Drugs from Canada Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-259/
MLA
"S. 259: Safe and Affordable Drugs from Canada Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-259/.
Bluebook (legal)
S. 259, 117th Cong. (2026), https://openamerica.io/bill/117-S-259/.
Markdown link
[S. 259: Safe and Affordable Drugs from Canada Act of 2021](https://openamerica.io/bill/117-S-259/)
Report a problem